Skip to main content

and
  1. Article

    Open Access

    Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study

    Drug retention is particularly relevant to assess long-term treatments. This real-world study mainly aimed to describe 1-year retention rate (RR) of subcutaneously administered tocilizumab (TCZ-SC) in patients...

    Pascal Hilliquin, Thomas Barnetche, Athan Baillet in Rheumatology and Therapy (2021)

  2. Article

    Open Access

    Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

    The main objective of this work was to assess the maintenance of effectiveness of subcutaneous tocilizumab 6 months after switching from intravenous to subcutaneous formulation in patients with rheumatoid arth...

    Jean Darloy, Nicolas Segaud, Jean-Hugues Salmon in Rheumatology and Therapy (2019)

  3. No Access

    Chapter

    Noninfectious Arthritis

    Noninfectious arthritis is among the most common musculoskeletal problems affecting the elderly. The resulting loss of mobility and physical independence can be particularly devastating. The clinical and radio...

    Ramon Gheno, Vittorio Pansini, Cristina Elena Rosca, René-Marc Flipo in Geriatric Imaging (2013)